Analystreport

X T L Biopharmaceuticals Ltd (NASDAQ: XTLB) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

XTL Biopharmaceuticals Ltd. - American Depositary Shares  (XTLB) 
US:NASDAQ Investor Relations: xtlbio.com